{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T20:47:29Z","timestamp":1748983649269},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,20]]},"DOI":"10.4103\/0366-6999.213962","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T13:55:14Z","timestamp":1504533314000},"page":"2176-2182","source":"Crossref","is-referenced-by-count":1,"title":["Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity"],"prefix":"10.1097","volume":"130","author":[{"given":"Gang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Ying","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Cheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Hai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210129","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s12032-014-0841-7","article-title":"Prognostic significance of serum albumin in patients with metastatic renal cell carcinoma","volume":"31","author":"Stenman","year":"2014","journal-title":"Med Oncol"},{"key":"R2-6-20210129","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","article-title":"Interleukin-6 signaling pathway in targeted therapy for cancer","volume":"38","author":"Guo","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"R3-6-20210129","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/0008-5472.CAN-13-1671","article-title":"HAVCR\/KIM-1 activates the IL-6\/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome","volume":"74","author":"Cuadros","year":"2014","journal-title":"Cancer Res"},{"key":"R4-6-20210129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2013.09.004","article-title":"Targeting interleukin-6 in inflammatory autoimmune diseases and cancers","volume":"141","author":"Yao","year":"2014","journal-title":"Pharmacol Ther"},{"key":"R5-6-20210129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0344-0338(86)80001-2","article-title":"Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics","volume":"181","author":"Thoenes","year":"1986","journal-title":"Pathol Res Pract"},{"key":"R6-6-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2012.06.006","article-title":"An overview of renal cell cancer: Pathology and genetics","volume":"23","author":"Moch","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"R7-6-20210129","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00261-016-0692-0","article-title":"Renal cell carcinoma: Staging and surveillance","volume":"41","author":"Dunnick","year":"2016","journal-title":"Abdom Radiol (NY"},{"key":"R8-6-20210129","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/tbj.12777","article-title":"Single-base LOH can be used as specific marker to classify BRCAx familial breast cancer into more homogenous subtypes","volume":"23","author":"Downs","year":"2017","journal-title":"Breast J"},{"key":"R9-6-20210129","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2484\/rcr.v2i3.72","article-title":"Paraneoplast renal cell carcinoma with paraneoplastic manifestations: Imaging with CT and F-18 FDG PET\/CTic manifestations of renal cell carcinoma","volume":"2","author":"Nguyen","year":"2015","journal-title":"Radiol Case Rep"},{"key":"R10-6-20210129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00000421-199906000-00003","article-title":"Renal cell carcinoma: A paradigm of lanthanic disease","volume":"22","author":"Papac","year":"1999","journal-title":"Am J Clin Oncol"},{"key":"R11-6-20210129","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000353401","article-title":"Prognostic impact of intratumoral C-reactive protein expression in patients with clear cell renal cell carcinoma","volume":"92","author":"Can","year":"2014","journal-title":"Urol Int"},{"key":"R12-6-20210129","first-page":"1801","article-title":"Serum amyloid A: A biomarker for renal cancer","volume":"32","author":"Fischer","year":"2012","journal-title":"Anticancer Res"},{"key":"R13-6-20210129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11010-013-1574-1","article-title":"Docosahexaenoic acid and eicosapentaenoic acid reduce C-reactive protein expression and STAT3 activation in IL-6-treated HepG2 cells","volume":"377","author":"Wang","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"R14-6-20210129","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1442-2042.2006.01563.x","article-title":"Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma","volume":"13","author":"Ito","year":"2006","journal-title":"Int J Urol"},{"key":"R15-6-20210129","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.urolonc.2011.08.012","article-title":"Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC)","volume":"31","author":"Singh","year":"2013","journal-title":"Urol Oncol"},{"key":"R16-6-20210129","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2559.2004.01884.x","article-title":"Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes","volume":"44","author":"Nagy","year":"2004","journal-title":"Histopathology"},{"key":"R17-6-20210129","first-page":"455","article-title":"Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma","volume":"63","author":"S\u00fck\u00f6sd","year":"2003","journal-title":"Cancer Res"},{"key":"R18-6-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/(SICI)1098-2264(199601)15:1<64::AID-GCC9>3.0.CO;2-2","article-title":"Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis","volume":"15","author":"van den Berg","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"R19-6-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/bfgp\/elm007","article-title":"Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease","volume":"6","author":"Angeloni","year":"2007","journal-title":"Brief Funct Genomic Proteomic"},{"key":"R20-6-20210129","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2362.2007.01806.x","article-title":"Associations between VHL genotype and clinical phenotype in familial von Hippel-Lindau disease","volume":"37","author":"Huang","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"R21-6-20210129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<151::AID-PATH928>3.0.CO;2-R","article-title":"Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas","volume":"183","author":"Schullerus","year":"1997","journal-title":"J Pathol"},{"key":"R22-6-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1098-2264(199612)17:4<215::AID-GCC3>3.0.CO;2-6","article-title":"Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas","volume":"17","author":"B\u00e9roud","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"R23-6-20210129","doi-asserted-by":"crossref","first-page":"e1361","DOI":"10.1097\/MD.0000000000001361","article-title":"Retrospective analysis of the efficacy and safety of sorafenib in Chinese patients with metastatic renal cell carcinoma and prognostic factors related to overall survival","volume":"94","author":"Yu","year":"2015","journal-title":"Medicine (Baltimore"},{"key":"R24-6-20210129","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/modpathol.2011.107","article-title":"Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis","volume":"24","author":"Monzon","year":"2001","journal-title":"Mod Pathol"},{"key":"R25-6-20210129","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/(SICI)1097-0142(19960315)77:6<1154::AID-CNCR23>3.0.CO;2-#","article-title":"The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma","volume":"77","author":"Wu","year":"1996","journal-title":"Cancer"},{"key":"R26-6-20210129","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/PPO.0b013e3181a282d8","article-title":"Clinical manifestations and natural history of Hodgkin's lymphoma","volume":"15","author":"Connors","year":"2009","journal-title":"Cancer J"},{"key":"R27-6-20210129","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2141.2004.05353.x","article-title":"Effect of IL-6 promoter polymorphism on incidence and outcome in Hodgkin's lymphoma","volume":"128","author":"Cordano","year":"2005","journal-title":"Br J Haematol"},{"key":"R28-6-20210129","first-page":"535","article-title":"Detection of t(14;18), P53 and RAS gene mutations and quantification of residual disease in patients with B-cell non-Hodgkin's lymphoma","volume":"26","author":"Cikota","year":"2007","journal-title":"J Exp Clin Cancer Res"},{"key":"R29-6-20210129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1479-5876-12-151","article-title":"Synergistic effects of IL-4 and TNF\u03b1 on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation","volume":"12","author":"Quandt","year":"2014","journal-title":"J Transl Med"},{"key":"R30-6-20210129","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1021\/acs.jproteome.5b00692","article-title":"Combined analyses of the VHL and hypoxia signaling axes in an isogenic pairing of renal clear cell carcinoma cells","volume":"14","author":"Malec","year":"2015","journal-title":"J Proteome Res"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.213962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:44:33Z","timestamp":1623959073000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201709200-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,20]]},"references-count":30,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.213962","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9,20]]}}}